Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-09

Clinical Trial Update: A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Region [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of VTAMA (tapinarof) 1% cream for plaque psoriasis in the head and neck region has completed and results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VTAMA (Tapinarof) Cream, 1% (Tapinarof)

Snippet

Sponsor: Organon and Co | Conditions: Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2024-08-09